Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
90,189
-
Shares change
-
-53,388
-
Total reported value, excl. options
-
$7,533,644
-
Value change
-
-$4,130,827
-
Put/Call ratio
-
47.06%
-
Number of buys
-
3
-
Number of sells
-
-13
-
Price
-
$83.51
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q1 2021
27 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q1 2021.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90,189 shares
.
Largest 10 shareholders include SUSQUEHANNA INTERNATIONAL GROUP, LLP (47,354 shares), FLOW TRADERS U.S. LLC (13,213 shares), Traynor Capital Management, Inc. (8,599 shares), Virtu Financial LLC (8,210 shares), Capital Investment Advisors, LLC (3,005 shares), CITADEL ADVISORS LLC (2,873 shares), Tower Research Capital LLC (TRC) (2,707 shares), UBS Group AG (1,500 shares), SIMPLEX TRADING, LLC (1,203 shares), and Kelly Financial Services LLC (403 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.